Epstein Marie Insider Trades

Insider Trading History

Track insider trading activity for Epstein Marie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Principal Accounting Officer
Holding Value $16.8k 8,883 shares
Last Trade
Dec 02, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.34k 1,976 shares
$1.69
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Principal Accounting Officer
Holding Value $20.5k 10,859 shares
Last Trade
Jun 03, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.56k 1,806 shares
$1.42
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Principal Accounting Officer
Holding Value $23.9k 12,665 shares
Last Trade
Dec 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.5k 12,665 shares
$3.83
$1.89
Proteostasis Therapeutics
Proteostasis Therapeutics PTI
Principal Accounting Officer
Holding Value $14.8k 13,329 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.8k 13,329 shares
$1.11
$1.11
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Principal Accounting Officer
Holding Value $25.2k 13,329 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$238k 13,329 shares
$17.89
$1.89
Yumanity Therapeutics
Yumanity Therapeutics YMTX
Principal Accounting Officer
Holding Value $72.5k 38,373 shares
Last Trade
Dec 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3k 42,589 shares
$1.11
$1.89

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up